Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.
Johnson & Johnson is set to Participate in the Credit Suisse 7th Annual Healthcare Conference. The conference will be held on Tuesday, November 13, 2018, in Scottsdale Arizona at The Phoenician. Scott White, Company Group Chairman, North America Pharmaceuticals will represent Johnson & Johnson during a session scheduled for 8:35 a.m. MST.
For those investors and other interested parties, there will be a webcast of the session available through the Johnson & Johnson website at www.investor.jnj.com. For those unable to listen in at the time of the session, a webcast replay will be available two hours after the live webcast.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com
with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!
Johnson & Johnson to Participate in the Credit Suisse 27th Annual Healthcare Conference
NEW BRUNSWICK, N.J., Nov. 6, 2018 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13th, at The Phoenician in Scottsdale, AZ. Scott White, Company Group Chairman, North America Pharmaceuticals will represent the Company in a session scheduled at 8…..